By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Cancer Institute is seeking clinically annotated biospecimens for a number of cancer types that it will use in The Cancer Genome Atlas (TCGA) program, a collaboration with the National Human Genome Research Institute which aims to study at least 20 cancers over the next five years.

NCI expects that it will need more than 40,000 biosamples to supply TCGA over the coming years to study all of these cancer varieties.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.

Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.

Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.

Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.